Murine MHC class II H2-E binds Influenza H19 head distinct from the sialic acid binding site but sterically conflicts with TCR binding
Abstract
Receptor recognition by influenza A virus (IAV) hemagglutinin (HA) is a key determinant of viral entry and host range, traditionally-known to be mediated by sialylated glycans. Previous studies have suggested that major histocompatibility complex class II (MHC II), the antigen-presenting molecule recognized by CD4⁺ T cells, can serve as an entry receptor for several IAVs. The molecular basis of this alternative receptor recognition and its potential implications for MHC II-associated immune functions remain incompletely understood. Here, we report that in vitro expressed H19 bound murine H2-E (I-E), whereas H17 and MHC II from other species tested showed no detectable binding, and a 2.65 Å cryo-electron microscopy structure of the H19/H2-E complex was determined. The H2-E α1 domain binds the lateral surface of the HA head outside the canonical sialic acid-binding pocket, forming three contact regions without directly contacting the peptide presented by H2-E. The key residue candidates within the interaction interface indicate the species-dependent recognition of murine and mallard compared to other species. We also observed two or three H2-E bound to a single H19 trimer, but with limited particle numbers. The structure of two H2-E with one H19 trimer was solved to 6.06 Å and an apo H19 structure was also solved here to 2.67 Å. Structural superposition suggested steric incompatibility of the H19 docking with T cell receptor or HLA-DM binding configurations. These findings define the molecular architecture of H19/MHC II complex recognition and suggest a potential link between influenza receptor usage and MHC II-associated immune functions.
References
1. Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol Rev. 1992;56(1):152-179. doi:10.1128/mr.56.1.152-179.1992
2. Yoon SW, Webby RJ, Webster RG. Evolution and ecology of influenza A viruses. Curr Top Microbiol Immunol. 2014;385:359-375. doi:10.1007/82_2014_396
3. Iuliano AD, Roguski KM, Chang HH, et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018;391(10127):1285-1300. doi:10.1016/S0140-6736(17)33293-2
4. Zhang W, Shi Y, Lu X, Shu Y, Qi J, Gao GF. An airborne transmissible avian influenza H5 hemagglutinin seen at the atomic level. Science. 2013;340(6139):1463-1467. doi:10.1126/science.1236787
5. Liu WJ, Wu Y, Bi Y, et al. Emerging HxNy influenza A viruses. Cold Spring Harb Perspect Med. 2022;12(2):a038406. doi:10.1101/cshperspect.a038406
6. Liu J, Xiao H, Lei F, et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science. 2005;309(5738):1206. doi:10.1126/science.1115273
7. Wang G, Zhan D, Li L, et al. H5N1 avian influenza re-emergence of Lake Qinghai: phylogenetic and antigenic analyses of the newly isolated viruses and roles of migratory birds in virus circulation. J Gen Virol. 2008;89(3):697-702. doi:10.1099/vir.0.83419-0
8. Stevens J, Blixt O, Tumpey TM, Taubenberger JK, Paulson JC, Wilson IA. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science. 2006;312(5772):404-410. doi:10.1126/science.1124513
9. Stevens J, Blixt O, Glaser L, et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol. 2006;355(5):1143-1155. doi:10.1016/j.jmb.2005.11.002
10. Shi Y, Zhang W, Wang F, et al. Structures and receptor binding of hemagglutinins from human-infecting H7N9 influenza viruses. Science. 2013;342(6155):243-247. doi:10.1126/science.1242917
11. Wang M, Zhang W, Qi J, et al. Structural basis for preferential avian receptor binding by the human-infecting H10N8 avian influenza virus. Nat Commun. 2015;6:5600. doi:10.1038/ncomms6600
12. Sun X, Shi Y, Lu X, et al. Bat-derived influenza hemagglutinin H17 does not bind canonical avian or human receptors and most likely uses a unique entry mechanism. Cell Rep. 2013;3(3):769-778. doi:10.1016/j.celrep.2013.01.025
13. Olajide OM, Osman MK, Robert J, et al. Evolutionarily conserved amino acids in MHC-II mediate bat influenza A virus entry into human cells. PLoS Biol. 2023;21(7):e3002182. doi:10.1371/journal.pbio.3002182
14. Karakus U, Thamamongood T, Ciminski K, et al. MHC class II proteins mediate cross-species entry of bat influenza viruses. Nature. 2019;567(7746):109-112. doi:10.1038/s41586-019-0955-3
15. Karakus U, Mena I, Kottur J, et al. H19 influenza A virus exhibits species-specific MHC class II receptor usage. Cell Host Microbe. 2024;32(7):1089-1102.e10. doi:10.1016/j.chom.2024.05.018
16. Osman MK, Robert J, Broich L, et al. The bat influenza A virus subtype H18N11 induces nanoscale MHCII clustering upon host cell attachment. Nat Commun. 2025;16(1):3847. doi:10.1038/s41467-025-58834-y
17. Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 2014;22(4):183-191. doi:10.1016/j.tim.2014.01.010
18. Brown JH, Jardetzky TS, Gorga JC, et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993;364(6432):33-39. doi:10.1038/364033a0
19. Roche PA, Furuta K. The ins and outs of MHC class II-mediated antigen processing and presentation. Nat Rev Immunol. 2015;15(4):203-216. doi:10.1038/nri3818
20. Giotis ES, Carnell G, Young EF, et al. Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor. Nat Microbiol. 2019;4(12):2035-2038. doi:10.1038/s41564-019-0517-3
21. Dadonaite B, Dosey A, Ahn JJ, et al. Defining the molecular interaction between influenza hemagglutinin and MHC-II. bioRxiv. Preprint posted online July 22, 2026. doi:10.64898/2026.07.17.738765
22. Cardenas M, Compton S, Caceres CJ, García-Sastre A, Perez DR, Rajao DS. MHC class II functions as a host-specific entry receptor for representative human and swine H3N2 influenza A viruses. Nat Commun. 2026;17(1):2560. doi:10.1038/s41467-026-69267-6
23. Ridgway JBB, Presta LG, Carter P. “Knobs-into-holes” engineering of antibody CH3 domains for heavy-chain heterodimerization. Protein Eng. 1996;9(7):617-621. doi:10.1093/protein/9.7.617
24. Chen J, Zhu X, Huo J, et al. A high-throughput immunopeptidome platform for MHC II alleles to characterize antigen-specific CD4+ T cells. Biomed Technol. 2025;12:100112. doi:10.1016/j.bmt.2025.100112
25. Iwashiro M, Kondo T, Shimizu T, et al. Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells. J Virol. 1993;67(8):4533-4542. doi:10.1128/JVI.67.8.4533-4542.1993
26. Song H, Hao T, Han P, et al. Receptor binding, structure, and tissue tropism of cattle-infecting H5N1 avian influenza virus hemagglutinin. Cell. 2025;188(4):919-929.e9. doi:10.1016/j.cell.2025.01.019
27. Punjani A, Rubinstein JL, Fleet DJ, Brubaker MA. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat Methods. 2017;14(3):290-296. doi:10.1038/nmeth.4169
28. Punjani A, Zhang H, Fleet DJ. Non-uniform refinement: adaptive regularization improves single-particle cryo-EM reconstruction. Nat Methods. 2020;17(12):1214-1221. doi:10.1038/s41592-020-00990-8
29. He J, Li T, Huang SY. Improvement of cryo-EM maps by simultaneous local and non-local deep learning. Nat Commun. 2023;14(1):3217. doi:10.1038/s41467-023-39031-1
30. Pettersen EF, Goddard TD, Huang CC, et al. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30(1):70-82. doi:10.1002/pro.3943
31. Afonine PV, Poon BK, Read RJ, et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr D Struct Biol. 2018;74(6):531-544. doi:10.1107/S2059798318006551
32. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr. 2010;66(4):486-501. doi:10.1107/S0907444910007493
33. Fereidouni S, Starick E, Karamendin K, et al. Genetic characterization of a new candidate hemagglutinin subtype of influenza A viruses. Emerg Microbes Infect. 2023;12(2):2225645. doi:10.1080/22221751.2023.2225645
34. Karakus U, Sempere Borau M, Martínez-Barragán P, et al. MHC class II proteins mediate sialic acid independent entry of human and avian H2N2 influenza A viruses. Nat Microbiol. 2024;9(10):2626-2641. doi:10.1038/s41564-024-01771-1
35. Ciminski K, Reuther P, Rijkers R, de Vries RP, Schwemmle M. The receptor landscape of influenza A viruses. J Virol. 2026;100(8):e01443-25. doi:10.1128/jvi.01443-25
36. de Vries E, Du W, Guo H, de Haan CAM. Influenza A virus hemagglutinin–neuraminidase–receptor balance: preserving virus motility. Trends Microbiol. 2020;28(1):57-67. doi:10.1016/j.tim.2019.08.010
37. Wrobel A, Robert J, Osman M, et al. H18 haemagglutinin binds MHC class II at a site distant from the canonical sialic-acid binding site. Research Square. Preprint posted online September 9, 2026. doi:10.21203/rs.3.rs-10549591/v1
38. Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994;368(6468):215-221. doi:10.1038/368215a0
39. Ayres CM, Baker BM. Peptide-dependent tuning of major histocompatibility complex motional properties and the consequences for cellular immunity. Curr Opin Immunol. 2022;76:102184. doi:10.1016/j.coi.2022.102184
40. Mullen MM, Haan KM, Longnecker R, Jardetzky TS. Structure of the Epstein–Barr virus gp42 protein bound to the MHC class II receptor HLA-DR1. Mol Cell. 2002;9(2):375-385. doi:10.1016/S1097-2765(02)00465-3
41. Smed-Sörensen A, Chalouni C, Chatterjee B, et al. Influenza A virus infection of human primary dendritic cells impairs their ability to cross-present antigen to CD8 T cells. PLoS Pathog. 2012;8(3):e1002572. doi:10.1371/journal.ppat.1002572
42. Ressing ME, van Leeuwen D, Verreck FAW, et al. Interference with T cell receptor–HLA-DR interactions by Epstein–Barr virus gp42 results in reduced T helper cell recognition. Proc Natl Acad Sci U S A. 2003;100(20):11583-11588. doi:10.1073/pnas.2034960100
43. Hennecke J, Carfi A, Wiley DC. Structure of a covalently stabilized complex of a human αβ T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 2000;19(21):5611-5624. doi:10.1093/emboj/19.21.5611
44. Reinherz EL, Tan K, Tang L, et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science. 1999;286(5446):1913-1921. doi:10.1126/science.286.5446.1913
45. Newell EW, Ely LK, Kruse AC, et al. Structural basis of specificity and cross-reactivity in T cell receptors specific for cytochrome c–I-Ek. J Immunol. 2011;186(10):5823-5832. doi:10.4049/jimmunol.1100197
46. Wu LC, Tuot DS, Lyons DS, Garcia KC, Davis MM. Two-step binding mechanism for T-cell receptor recognition of peptide–MHC. Nature. 2002;418(6897):552-556. doi:10.1038/nature00920
47. Pos W, Sethi DK, Call MJ, et al. Crystal structure of the HLA-DM–HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell. 2012;151(7):1557-1568. doi:10.1016/j.cell.2012.11.025
48. Jardetzky TS, Brown JH, Gorga JC, et al. Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature. 1994;368(6473):711-718. doi:10.1038/368711a0
49. Rödström KEJ, Elbing K, Lindkvist-Petersson K. Structure of the superantigen staphylococcal enterotoxin B in complex with TCR and peptide-MHC demonstrates absence of TCR-peptide contacts. J Immunol. 2014;193(4):1998-2004. doi:10.4049/jimmunol.1401268
50. Ciminski K, Ran W, Gorka M, et al. Bat influenza viruses transmit among bats but are poorly adapted to non-bat species. Nat Microbiol. 2019;4(12):2298-2309. doi:10.1038/s41564-019-0556-9
Metrics
DOI:
Submission ID:
Downloads
Posted
How to Cite
Download Citation
Declaration of Competing Interests
The authors declare no competing interests to disclose.
Copyright
The copyright holder for this preprint is the author/funder.

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.